LifespanningRx launches free peptide therapy explorer

LifespanningRx has launched Peptide Explorer, a free online tool designed to help people organize health goals and identify up to three peptide therapy categories to discuss with a clinician. The Miami-based platform says the tool is meant to cut through conflicting information and keep treatment decisions in licensed medical hands.

Why it matters: - Peptide therapies are drawing more public interest, but the information people find online is often inconsistent. - LifespanningRx is trying to turn that confusion into a structured, clinician-guided starting point. - The tool is designed to help users prepare for more focused conversations with healthcare professionals, not replace them.

What happened: - LifespanningRx on Aug. 31, 2026, launched Peptide Explorer, an online educational tool for people exploring peptide therapy categories tied to health and longevity goals. - The tool is free to use online. - Users answer a questionnaire about energy and metabolism, body composition, recovery, healthy aging, cognitive health, stress, skin and hair, gut support, sexual wellness and physical performance. - Based on those responses, the platform may surface up to three therapy candidates for further review with a licensed healthcare professional.

The details: - The experience takes about five minutes, according to LifespanningRx. - The system evaluates responses across 35 therapy families using 122 routing actions. - Safety-related answers can modify, restrict or prevent therapy candidates from being shown. - Certain responses can direct users toward appropriate medical care instead of therapy suggestions. - The tool does not diagnose conditions, prescribe treatment, recommend dosages or determine medical eligibility. - If a licensed clinician later determines treatment is appropriate, a patient-specific prescription may be sent to a qualified U.S. compounding pharmacy for fulfillment. - Users can access additional educational information through the LifespanningRx platform and request a clinician-guided evaluation.

Between the lines: - Founder and CEO Jean Fallacara framed the product as a response to confusion in the peptide market. - Fallacara said, “Peptides are not the problem. Confusion is.” - Fallacara also said the company created Peptide Explorer to give people a more organized starting point before they speak with a healthcare professional. - The launch fits LifespanningRx’s broader push to connect longevity education, digital guidance, clinical evaluation and patient support in one platform. - LifespanningRx says it wants to reduce reliance on generic online recommendations and help people arrive at better-informed clinical discussions.

What's next: - Users who want to move forward after seeing results can seek more educational material and request a clinician-guided evaluation. - Any therapy decision, dosage plan or monitoring approach remains the responsibility of a licensed healthcare professional after medical evaluation. - LifespanningRx says the platform will continue to support people exploring healthy aging, metabolic health, recovery, cellular health and physical performance.

The bottom line: - Peptide Explorer is an educational triage tool, not a medical decision engine, and its main job is to help users organize questions before they see a clinician.